EVP, Clinical Development
Avg Cost/Share
$0.79
Shares
3,282
Total Value
$2,592.78
Owned After
304,201
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Xu Cong Claire | NBP | EVP, Clinical Development | Aug 31, 2026 | Sell | $0.79 | 3,282 | $2,592.78 | 304,201 |